vs

Side-by-side financial comparison of BLACKBERRY Ltd (BB) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $141.8M, roughly 1.3× BLACKBERRY Ltd). BLACKBERRY Ltd runs the higher net margin — 9.7% vs -57.9%, a 67.5% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs -0.8%). Over the past eight quarters, BLACKBERRY Ltd's revenue compounded faster (17.8% CAGR vs 6.5%).

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

BB vs NEO — Head-to-Head

Bigger by revenue
NEO
NEO
1.3× larger
NEO
$186.7M
$141.8M
BB
Growing faster (revenue YoY)
NEO
NEO
+11.9% gap
NEO
11.1%
-0.8%
BB
Higher net margin
BB
BB
67.5% more per $
BB
9.7%
-57.9%
NEO
Faster 2-yr revenue CAGR
BB
BB
Annualised
BB
17.8%
6.5%
NEO

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
BB
BB
NEO
NEO
Revenue
$141.8M
$186.7M
Net Profit
$13.7M
$-108.0M
Gross Margin
77.5%
43.3%
Operating Margin
8.4%
46.9%
Net Margin
9.7%
-57.9%
Revenue YoY
-0.8%
11.1%
Net Profit YoY
224.5%
42.0%
EPS (diluted)
$0.02
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BB
BB
NEO
NEO
Q1 26
$186.7M
Q4 25
$141.8M
$190.2M
Q3 25
$129.6M
$187.8M
Q2 25
$121.7M
$181.3M
Q1 25
$141.7M
$168.0M
Q4 24
$143.6M
$172.0M
Q3 24
$126.2M
$167.8M
Q2 24
$123.4M
$164.5M
Net Profit
BB
BB
NEO
NEO
Q1 26
$-108.0M
Q4 25
$13.7M
Q3 25
$13.3M
$-27.1M
Q2 25
$1.9M
$-45.1M
Q1 25
$-7.4M
$-25.9M
Q4 24
$-10.5M
Q3 24
$-19.7M
$-17.7M
Q2 24
$-41.4M
$-18.6M
Gross Margin
BB
BB
NEO
NEO
Q1 26
43.3%
Q4 25
77.5%
43.8%
Q3 25
74.5%
42.8%
Q2 25
74.2%
42.6%
Q1 25
73.5%
43.6%
Q4 24
78.1%
44.9%
Q3 24
70.2%
44.6%
Q2 24
72.9%
44.1%
Operating Margin
BB
BB
NEO
NEO
Q1 26
46.9%
Q4 25
8.4%
-7.1%
Q3 25
8.9%
-14.4%
Q2 25
1.6%
-26.3%
Q1 25
-5.6%
-16.6%
Q4 24
13.6%
-10.7%
Q3 24
1.7%
-12.6%
Q2 24
-10.5%
-13.3%
Net Margin
BB
BB
NEO
NEO
Q1 26
-57.9%
Q4 25
9.7%
Q3 25
10.3%
-14.4%
Q2 25
1.6%
-24.9%
Q1 25
-5.2%
-15.4%
Q4 24
-7.3%
Q3 24
-15.6%
-10.5%
Q2 24
-33.5%
-11.3%
EPS (diluted)
BB
BB
NEO
NEO
Q1 26
$-0.13
Q4 25
$0.02
Q3 25
$0.02
Q2 25
$0.00
Q1 25
$-0.01
Q4 24
$-0.02
Q3 24
$-0.03
Q2 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BB
BB
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$304.2M
$146.1M
Total DebtLower is stronger
$196.2M
Stockholders' EquityBook value
$741.1M
$828.8M
Total Assets
$1.2B
$1.3B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BB
BB
NEO
NEO
Q1 26
$146.1M
Q4 25
$304.2M
$159.6M
Q3 25
$290.5M
$164.1M
Q2 25
$306.6M
$154.7M
Q1 25
$337.8M
$346.2M
Q4 24
$220.0M
$367.0M
Q3 24
$211.0M
$362.0M
Q2 24
$229.0M
$355.1M
Total Debt
BB
BB
NEO
NEO
Q1 26
Q4 25
$196.2M
$341.9M
Q3 25
$195.9M
Q2 25
$195.6M
Q1 25
$195.3M
Q4 24
$541.1M
Q3 24
Q2 24
Stockholders' Equity
BB
BB
NEO
NEO
Q1 26
$828.8M
Q4 25
$741.1M
$836.6M
Q3 25
$725.1M
$838.3M
Q2 25
$725.1M
$854.0M
Q1 25
$719.9M
$888.3M
Q4 24
$725.2M
$902.3M
Q3 24
$732.1M
$908.2M
Q2 24
$742.6M
$915.9M
Total Assets
BB
BB
NEO
NEO
Q1 26
$1.3B
Q4 25
$1.2B
$1.4B
Q3 25
$1.2B
$1.4B
Q2 25
$1.2B
$1.4B
Q1 25
$1.3B
$1.6B
Q4 24
$1.3B
$1.6B
Q3 24
$1.3B
$1.6B
Q2 24
$1.3B
$1.6B
Debt / Equity
BB
BB
NEO
NEO
Q1 26
Q4 25
0.26×
0.41×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.27×
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BB
BB
NEO
NEO
Operating Cash FlowLast quarter
$18.3M
$-8.1M
Free Cash FlowOCF − Capex
$17.4M
FCF MarginFCF / Revenue
12.3%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$42.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BB
BB
NEO
NEO
Q1 26
$-8.1M
Q4 25
$18.3M
$1.3M
Q3 25
$3.9M
$8.9M
Q2 25
$-18.0M
$20.3M
Q1 25
$41.6M
$-25.3M
Q4 24
$6.0M
$9.8M
Q3 24
$-16.0M
$9.2M
Q2 24
$-15.1M
$13.9M
Free Cash Flow
BB
BB
NEO
NEO
Q1 26
Q4 25
$17.4M
$-6.5M
Q3 25
$3.1M
$570.0K
Q2 25
$-18.9M
$14.0M
Q1 25
$41.2M
$-29.8M
Q4 24
$5.2M
$-1.8M
Q3 24
$-16.5M
$-1.6M
Q2 24
$-16.5M
$814.0K
FCF Margin
BB
BB
NEO
NEO
Q1 26
Q4 25
12.3%
-3.4%
Q3 25
2.4%
0.3%
Q2 25
-15.5%
7.7%
Q1 25
29.1%
-17.8%
Q4 24
3.6%
-1.0%
Q3 24
-13.1%
-0.9%
Q2 24
-13.4%
0.5%
Capex Intensity
BB
BB
NEO
NEO
Q1 26
Q4 25
0.6%
4.1%
Q3 25
0.6%
4.4%
Q2 25
0.7%
3.5%
Q1 25
0.3%
2.7%
Q4 24
0.6%
6.7%
Q3 24
0.4%
6.4%
Q2 24
1.1%
8.0%
Cash Conversion
BB
BB
NEO
NEO
Q1 26
Q4 25
1.34×
Q3 25
0.29×
Q2 25
-9.47×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

NEO
NEO

Segment breakdown not available.

Related Comparisons